12:20 PM EDT, 10/28/2025 (MT Newswires) -- (Updates with recent stock price movement in the headline and first paragraph.)

Arcutis Biotherapeutics' ( ARQT ) shares were up nearly 27% in recent Tuesday trading after the company swung to a Q3 profit as revenue increased.

The company posted Q3 earnings of $0.06 per diluted share, swinging from a loss of $0.33 a year earlier.

Four analysts polled by FactSet expected a loss of $0.10.

Revenue for the quarter ended Sept. 30 was $99.2 million, compared with $44.8 million a year earlier.

Analysts polled by FactSet expected $87 million.

For 2026, Arcutis said it expects net product revenue to be between $455 million and $470 million.

Price: 24.85, Change: +5.21, Percent Change: +26.50